Transgenics can substantially reduce capital investment and lower production costs through economies of scale and more flexible scale-up.
Nancy Markley
Advertisement
Nancy Markley, PhD is director of business development at SemBioSys Genetics Inc.
Articles by Nancy Markley
Advertisement
Latest Updated Articles
Producing Proteins Using Transgenic Oilbody-Oleosin TechnologyPublished: June 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
